Studies suggest a role for brain-derived GLP-1 in the control of eating and reward (80, 81), but there is no evidence that peripherally administered GLP-1RAs can directly access GLP-1Rs in these regions, as demonstrated by the lack of fluorescently labeled semaglutide in these brain nuclei
Communication is essential: Bring complete documentation of your GLP-1 use including medication name, dose, duration, and last injection date
Leptin drops, ghrelin rises, and insulin resistance increases, which intensifies hunger and promotes weight regain
That is more weight lost in less time than either semaglutide or tirzepatide achieved in their respective trials
Crucially, they trigger insulin release only when glucose is already present in the bloodstream, minimizing the risk of dangerous hypoglycemia seen with some older diabetes drugs